Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

258P - The impact of total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC): A real-world Italian multicentric experience

Date

27 Jun 2024

Session

Poster Display session

Presenters

Federica Lo Prinzi

Citation

Annals of Oncology (2024) 35 (suppl_1): S106-S118. 10.1016/annonc/annonc1480

Authors

F. Lo Prinzi1, V. Picone2, F. Zoratto3, E. Dell'Aquila4, G. Caira5, M. Veroli6, G. Arrivi7, A. Emiliani8, M. Schirripa9, R. Ajdhoni10, E. Bengala11, A. Spring12, M.V. Bonomo13, B. Di Cocco14, C. Fiore9, M.G. Polito1, D. Giannarelli15, A. Torsello16

Author affiliations

  • 1 Policlinico Universitario Campus Bio-Medico, Rome/IT
  • 2 Department of Radiology, Oncology and Pathology, Policlinico Umberto I, Sapienza University of Rome, Rome/IT
  • 3 Ospedale Santa Maria Goretti - ASL Latina, Latina/IT
  • 4 IRCCS Regina Elena National Cancer Institute, IT-00128 - Rome/IT
  • 5 Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy, Rome/IT
  • 6 Sapienza Università di Roma, Rome/IT
  • 7 Azienda Ospedaliera Sant'Andrea, Rome/IT
  • 8 Isola Tiberina Hospital-Gemelli Isola, Rome/IT
  • 9 Ospedale Belcolle - ASL Viterbo, Viterbo/IT
  • 10 Universita Degli Studi di Roma Tor Vergata, Roma RM/IT
  • 11 IRCCS Regina Elena National Cancer Institute, Rome/IT
  • 12 Fondazione Policlinico Universitario Agostino Gemelli–IRCCS, Università Cattolica del Sacro Cuore, Rome/IT
  • 13 Policlinico Tor Vergata, Rome/IT
  • 14 Ospedale Santa Maria Goretti - Pronto Soccorso, Latina/IT
  • 15 Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome/IT
  • 16 Ospedale San Giovanni, Rome/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 258P

Background

TNT has recently changed treatment strategy of LARC thanks to increased clinical and pathological complete responses (cCR and pCR) and the possibility of avoiding major surgery by adopting a watch and wait (W-W) approach in case of cCR. The aim of this study is to evaluate in a real word retrospective analysis the applicability of TNT and its implications.

Methods

In 6 centers we evaluated 185 LARC microsatellite stables patients (pts), M/F=107/78, with a median distance from anal verge 5-7 cm. 27 pts classified as cT3N0/c(any)TN+, underwent surgery followed by RT/CHT. The other 158 pts were treated with a neoadjuvant approach: 97 pts (62%) with standard RT/CHT (group A) and 61 pts (38%) with TNT (group B). Pts with bulky disease cT4N+ were 33% group B and 9% group A. Group B chemotherapy was FOLFOX/XELOX (55%) and FOLFOXIRI (45%).

Results

Surgery was performed in 124 pts, 84 pts (86%) group A and 40 pts (65%) group B (p=0.015), with 12% transanal resection in group B and 0% in group A. pCR in group A was 18% (radiological cCR 40% and near cCR/cRP 60%) vs 28% in group B (radiological cCR 45%, near cCR/cPR 36%, cSD 18%). In pts not achieving a pCR, radiological cCR was 10%. W-W was offered to 4 pts (4%) group A and 10 pts (16%) group B who had cCR/near cCR: 1 pt in group B recurred after 1y and was treated with surgery. Overall, the 2y-DFS was 75,3% and the 5y-DFS 51,9%. In pts with upfront surgery 2y-DFS was 78,1% and 5y-DFS 71%, in pts treated with neoadjuvant therapy 2y-DFS was 73,9% and 5y-DFS 45,1%, probably because of more advanced disease. In neoadjuvant pts, 2y-DFS was 76,5% in group A vs 70,2% in group B and 5y-DFS was 52,7% vs 23,9%, respectively(p=0.043). In pts with bulky cT4N+, 5y-DFS was 24,7% in group B and 0% in group A, confirming long-term disease control in TNT. In the general population 2y-OS was 92,5% and 5y-OS 80%. For surgery upfront 2y-OS was 84,8% and 5y-OS 77,8%, in neoadjuvant pts 2y-OS 93,2% and 5y-OS 84,2% (numerically superior OS but p value not significant).

Conclusions

In our neoadjuvant population, TNT confirmed an increase in pCR but also in radiological major response. This encourages conservative transanal surgery or W-W when a multidisciplinary approach is strictly applied. This strategy needs to be further implemented.

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.